Page 19 - பல்கலைக்கழகம் ஆஃப் ஆஸ்திரேலியா News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Científicos de Australia aportan nuevos datos sobre las galaxias
prensa-latina.cu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prensa-latina.cu Daily Mail and Mail on Sunday newspapers.
La población mundial de tiburones y rayas se desplomó más del 70%
ecoportal.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ecoportal.net Daily Mail and Mail on Sunday newspapers.
Phát hiện mới cho thấy có thể vẫn sống lâu mà không cần phải ăn ít đi - Sức khỏe
vietgiaitri.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from vietgiaitri.com Daily Mail and Mail on Sunday newspapers.
El Inta suma tecnología inteligente a la ganadería
ellitoral.com.ar - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ellitoral.com.ar Daily Mail and Mail on Sunday newspapers.
US giant Merck stops development of two COVID-19 vaccine candidates
Both V590 and V591 were generally well tolerated, but the immune responses were inferior to those seen following natural infection and those reported for other COVID-19 vaccines, said Merck January 25, 2021 / 06:57 PM IST
Merck will focus its research strategy and production capabilities on advancing therapeutic drug candidates, MK-4482 and MK-7110. (Representative image)
US pharmaceutical gaint Merck, which is known in India as MSD, on January 25 said it is discontinuing development of its COVID-19 vaccine candidates, V590 and V591, and plans to focus its research strategy and production capabilities on advancing therapeutic drug candidates, MK-4482 and MK-7110.